PPARα激动剂对新生血管性年龄相关性黄斑变性模型中眼部新生血管的治疗作用
研究评估非诺贝酸(Feno-FA)在激光诱导脉络膜新生血管大鼠和Vldlr-/-小鼠模型中对眼部新生血管的作用及PPARα依赖性;Feno-FA显著减少血管渗漏、CNV体积及视网膜下和视网膜内新生血管,下调VEGF、TNF-α、ICAM-1并减少视网膜白细胞黏附;Pparα-/-小鼠CNV更严重且Feno-FA获益被消除,结论为Feno-FA通过PPARα依赖机制发挥治疗作用。
要点
- Feno-FA减少激光诱导CNV大鼠和Vldlr-/-小鼠的血管渗漏。
- Feno-FA减少CNV大鼠CNV体积并抑制Vldlr-/-小鼠SRNV和IRNV。
- PPARα敲除加重CNV并消除Feno-FA对CNV的获益。
核心结论
- Feno-FA通过PPARα依赖机制对重现新生血管性AMD的模型中的眼部新生血管具有治疗作用。
研究设计与样本
- 研究采用激光诱导脉络膜新生血管(CNV)大鼠和极低密度脂蛋白受体敲除(Vldlr-/-)小鼠,每日腹腔注射Feno-FA或溶媒。
- 进一步使用Pparα-/-小鼠和年龄匹配野生型(WT)小鼠进行激光诱导CNV并给予Feno-FA以探索机制。
主要发现
- Feno-FA显著减少CNV大鼠和Vldlr-/-小鼠的血管渗漏。
- Feno-FA减少激光诱导CNV大鼠的CNV体积,并抑制Vldlr-/-小鼠的视网膜下新生血管(SRNV)和视网膜内新生血管(IRNV)。
- Feno-FA下调CNV大鼠眼杯内炎症因子VEGF、TNF-α和细胞间黏附分子-1(ICAM-1)的表达,并减少Vldlr-/-小鼠视网膜黏附白细胞。
- 与WT小鼠相比,Pparα-/-小鼠发生更严重的CNV,且PPARα敲除消除了Feno-FA对CNV的有益作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study was designed to evaluate effects of fenofibric acid (Feno-FA), a peroxisome proliferator-activated receptor-alpha (PPARα) agonist, on ocular neovascularization (NV) in models recapitulating neovascular age-related macular degeneration (AMD), and to explore whether the effects are PPARα dependent. METHODS: Laser-induced choroidal NV (CNV) in rats and very low-density lipoprotein receptor knockout (Vldlr-/-) mice received daily intraperitoneal injections of Feno-FA or vehicle. Vascular leakage was examined by fundus fluorescein angiography and permeability assay using Evans blue as tracer. In CNV rats, severity of CNV was evaluated by CNV areas and CNV volume. In Vldlr-/- mice, subretinal NV (SRNV) and intraretinal NV (IRNV) were quantified in choroid flat mount and retina flat mount, respectively. Inflammatory factors were measured using Western blotting and retinal leukostasis assay. Further, Pparα-/- mice and age-matched wild-type (WT) mice were used for laser-induced CNV and treated with Feno-FA to explore the underlying mechanism. RESULTS: Feno-FA significantly reduced vascular leakage in CNV rats and Vldlr-/- mice, reduced CNV volume in laser-induced CNV rats, and suppressed SRNV and IRNV in Vldlr-/- mice. In addition, Feno-FA downregulated the expression of inflammatory factors, including VEGF, TNF-α, and intercellular cell adhesion molecule-1 (ICAM-1), in the eyecups of CNV rats and decreased adherent retinal leukocytes in Vldlr-/- mice. Furthermore, Pparα-/- mice developed more severe CNV compared with WT mice, and PPARα knockout abolished the beneficial effects of Feno-FA on CNV. CONCLUSIONS: Feno-FA has therapeutic effects on ocular NV in models recapitulating neovascular AMD through a PPARα-dependent mechanism.
引用
- Qiu F, Matlock G, Chen Q, et al. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017. PMID: 28980001. doi:10.1167/iovs.17-22091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。